ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.16
-0.18%
US Tech 100
19,436.00
-0.73%
S&P 500
5,738.17
-0.13%
US Dollar vs CAD
1.35235
0.00%
Bitcoin
65,502.80
-0.56%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Plus Therapeutics Inc (PSTV)

  7. Plus Therapeutics Inc (PSTV) News

PSTV

Plus Therapeutics (PSTV)

Plus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PSTV
DateTimeSourceHeadlineSymbolCompany
09/18/20246:30AMGlobeNewswire Inc.Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
09/17/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/16/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/13/20245:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/13/20245:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/12/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/11/20245:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/11/20245:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/06/20243:52PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
09/06/20243:47PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
09/04/20246:30AMGlobeNewswire Inc.Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/23/20243:31PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PSTVPlus Therapeutics Inc
08/15/20243:53PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
08/15/20243:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
08/14/20243:48PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
08/14/20243:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTVPlus Therapeutics Inc
08/14/20243:16PMGlobeNewswire Inc.Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
08/14/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
08/13/20246:30AMGlobeNewswire Inc.Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/12/20246:30AMGlobeNewswire Inc.Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/08/20246:30AMGlobeNewswire Inc.Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:PSTVPlus Therapeutics Inc
07/25/20246:30AMGlobeNewswire Inc.Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO ConferenceNASDAQ:PSTVPlus Therapeutics Inc
07/12/20243:40PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PSTVPlus Therapeutics Inc
07/10/202411:12AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PSTVPlus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PSTV

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
BCAP
Baron Capital Enterprise (CE)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
USOTC
VPLM
Voip Pal Com (QB)
USOTC
TXTM
ProText Mobility (PK)
NASDAQ
AVXL
Anavex Life Sciences
NYSE
AMC
AMC Entertainment
NASDAQ
NB
NioCorp Developments
USOTC
RNVA
Rennova Health (CE)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
MULN
Mullen Automotive
USOTC
NBRI
North Bay Resources (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved